Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Kjeld Schmiegelow; Ibrahim Al-Modhawi; Mette Klarskov Andersen; Mikael Berendtz; Erik Forestier; Henrik Hasle; Mats Heyman; Jon Kristinsson; Jacob Nersting; Randi Nygaard; Anne Louise Svendsen; Kim Vettenranta; Richard Weinshilboum

doi:10.1182/blood-2009-03-210195

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

Kjeld Schmiegelow, Ibrahim Al-Modhawi, Mette Klarskov Andersen, Mikael Berendtz, Erik Forestier, Henrik Hasle, Mats Heyman, Jon Kristinsson, Jacob Nersting, Randi Nygaard, Anne Louise Svendsen, Kim Vettenranta, Richard Weinshilboum

Pharmacology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	6258-6259
Number of pages	2
Journal	Blood
Volume	113
Issue number	24
DOIs	https://doi.org/10.1182/blood-2009-03-210195
State	Published - 2009

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2009-03-210195

Cite this

Schmiegelow, K., Al-Modhawi, I., Andersen, M. K., Berendtz, M., Forestier, E., Hasle, H., Heyman, M., Kristinsson, J., Nersting, J., Nygaard, R., Svendsen, A. L., Vettenranta, K., & Weinshilboum, R. (2009). Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms? Blood, 113(24), 6258-6259. https://doi.org/10.1182/blood-2009-03-210195

Schmiegelow, K, Al-Modhawi, I, Andersen, MK, Berendtz, M, Forestier, E, Hasle, H, Heyman, M, Kristinsson, J, Nersting, J, Nygaard, R, Svendsen, AL, Vettenranta, K & Weinshilboum, R 2009, 'Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?', Blood, vol. 113, no. 24, pp. 6258-6259. https://doi.org/10.1182/blood-2009-03-210195

@article{b2858cef5b214fcf847ba14752592a57,

title = "Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?",

author = "Kjeld Schmiegelow and Ibrahim Al-Modhawi and Andersen, {Mette Klarskov} and Mikael Berendtz and Erik Forestier and Henrik Hasle and Mats Heyman and Jon Kristinsson and Jacob Nersting and Randi Nygaard and Svendsen, {Anne Louise} and Kim Vettenranta and Richard Weinshilboum",

year = "2009",

doi = "10.1182/blood-2009-03-210195",

language = "English (US)",

volume = "113",

pages = "6258--6259",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "24",

}

TY - JOUR

T1 - Response

T2 - Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

AU - Schmiegelow, Kjeld

AU - Al-Modhawi, Ibrahim

AU - Andersen, Mette Klarskov

AU - Berendtz, Mikael

AU - Forestier, Erik

AU - Hasle, Henrik

AU - Heyman, Mats

AU - Kristinsson, Jon

AU - Nersting, Jacob

AU - Nygaard, Randi

AU - Svendsen, Anne Louise

AU - Vettenranta, Kim

AU - Weinshilboum, Richard

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=70449375323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449375323&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-03-210195

DO - 10.1182/blood-2009-03-210195

M3 - Letter

AN - SCOPUS:70449375323

SN - 0006-4971

VL - 113

SP - 6258

EP - 6259

JO - Blood

JF - Blood

IS - 24

ER -

Response: Could mutations in the hypoxanthine-guanine phosphoribosyl transferase gene induced by thiopurine therapy promote the development of second malignant neoplasms?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this